BF Biosciences inks deal with Lucky Core

MG News | September 04, 2024 at 10:30 AM GMT+05:00

Add Mettisglobal as a Trusted Source on Google

0:00

September 04, 2024 (MLN): BF Biosciences Limited (BFBL)has entered into a contract manufacturing and supply agreement with Lucky Core Industries Limited (LCI) for the products "Esopase IV 40 mg" & "Etipro IV 40 mg", the company's filing on PSX revealed.

BFBL is a subsidiary of Ferozsons Laboratories Limited (PSX: FEROZ).

In August, BF Biosciences successfully launched human insulin under the brand name "Ferulin".

BF Biosciences was established exclusively for the manufacture of biologicals and it is the first and only company in Pakistan currently to have a biotech manufacturing facility.

Copyright Mettis Link News

Related News

PSX Closing Bell: Stays on the Front Foot

Pak-Qatar Family Takaful earns global recognition

KSTM mill operations stay suspended in Q4

Name	Price/Vol	%Chg/NChg
KSE100	184,520.96 423.48M	0.26% 470.86
ALLSHR	111,273.74 986.42M	0.44% 483.91
KSE30	55,083.19 197.44M	0.25% 138.98
KMI30	261,314.51 141.59M	0.26% 679.64
KMIALLSHR	71,698.64 555.80M	0.45% 320.42
BKTi	51,680.94 85.40M	0.11% 56.48
OGTi	37,287.90 17.12M	0.93% 345.12

Symbol	Bid/Ask	High/Low

Name	Last	High/Low	Chg/%Chg
BITCOIN FUTURES	62,155.00	62,265.00 59,710.00	1975.00 3.28%
BRENT CRUDE	70.93	71.22 70.14	-0.64 -0.89%
RICHARDS BAY COAL MONTHLY	107.50	0.00 0.00	0.30 0.28%
ROTTERDAM COAL MONTHLY	120.10	121.40 119.50	1.00 0.84%
USD RBD PALM OLEIN	1,135.00	1,135.00 1,135.00	0.00 0.00%
CRUDE OIL - WTI	67.85	68.24 67.04	-0.73 -1.06%
SUGAR #11 WORLD	15.12	15.17 14.93	0.13 0.87%